Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Pimecrolimus 1% Cream in the Treatment of Cutaneous Lesions of Pemphigus Vulgaris: A Double-Blind, Placebo-Controlled Clinical Trial Pubmed



Iraji F1 ; Asilian A1 ; Siadat AH1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Dermatology, Isfahan University of Medical Sciences Skin Diseases, Leishmaniais Research Center, Isfahan, Iran

Source: Journal of Drugs in Dermatology Published:2010


Abstract

Background: Pemphigus vulgaris (PV) is a chronic, bullous disorder that is usually characterized by the presence of bulla and erosion on the skin and mucosa. Many studies on PV focus on the use of topical non-steroid agents. One of these agents is pimecrolimus; its efficacy is established in some inflammatory and autoimmune disorders such as oral and genital lichen planus. Patients, Materials and Methods: This was a double-blind study that was performed in 11 patients with confirmed diagnosis of PV. Patients under treatment with systemic steroid and azathioprine who had bilateral symmetrical oral lesions were selected and right- or left-sided lesions of those identified were randomized to be treated either by pimecrolimus 1% cream or placebo. The largest diameter of lesions was measured at the baseline and every 15 days for two times. Epithelization Index (EI) was calculated and data were analyzed with a program for statistical analysis. Results: Overall, 11 patients (62 cutaneous lesions; 31 lesions in the pimecrolimus group and 31 lesions in the placebo group) with cutaneous lesions of the pemphigus vulgaris were included in this study. At the end of day 15, there was significant difference regarding EI between the pimecrolimus and placebo groups. In addition, EI was significantly different at the end of study (day 30) in favor of pimecrolimus group (P=0.000). Conclusion: Pimecrolimus can be used as an effective and safe adjunctive treatment for cutaneous lesions of pemphigus vulgaris. Copyright © 2010 Journal of Drugs in Dermatology.
Other Related Docs
9. The Efficacy of Acyclovir in Treatment of the Pemphigus Vulgaris, Journal of Research in Medical Sciences (2013)
10. Does Pemphigus Vulgaris Affect Oral Health Related Quality of Life?, Natural and Life Sciences Communications (2023)
14. Pemphigus Vulgaris in a Patient With Multiple Sclerosis: A Case Report With 7 Years of Follow Up, Journal of Research in Dental and Maxillofacial Sciences (2023)